BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16969731)

  • 1. [Difficult AV optimization in a patient with a biventricular implantable cardioverter defibrillator].
    Israel CW; Ehrlich JR; Britten M
    Herzschrittmacherther Elektrophysiol; 2006 Sep; 17(3):174-9. PubMed ID: 16969731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A life-threatening arrhythmia induced by inappropriate activation of an implantable cardioverter defibrillator.
    Kadmon E; Kusniec J; Strasberg B
    Europace; 2009 Dec; 11(12):1716-8. PubMed ID: 19762330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 4. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.
    Kadish A; Mehra M
    Circulation; 2005 Jun; 111(24):3327-35. PubMed ID: 15967863
    [No Abstract]   [Full Text] [Related]  

  • 5. Pacing during a wide complex rhythm: implantable cardioverter defibrillator malfunction or not?
    Wood MA
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):114-5. PubMed ID: 15028085
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost advantage of different cardioverter-defibrillator devices.
    Veenhuyzen GD
    J Am Coll Cardiol; 2006 Jul; 48(2):418-9; author reply 419. PubMed ID: 16843205
    [No Abstract]   [Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator shocks and their adverse impact on patient-centered outcomes: fact or fiction?
    Pedersen SS; van den Broek KC
    J Am Coll Cardiol; 2008 Sep; 52(12):1037-8; author reply 1038. PubMed ID: 18786489
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
    Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
    J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillator after left ventricular reconstruction?
    Sartipy U; Albåge A; Lindblom D
    J Thorac Cardiovasc Surg; 2006 May; 131(5):1210-1; author reply 1211. PubMed ID: 16678631
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergency Care of Patients with Pacemakers and Defibrillators.
    Allison MG; Mallemat HA
    Emerg Med Clin North Am; 2015 Aug; 33(3):653-67. PubMed ID: 26226872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular bigeminy as a cause of CRT inefficacy and inappropriate cardioverter-defibrillator intervention].
    Oreziak A; Przybylski A; Walczak F
    Kardiol Pol; 2009 Jul; 67(7):807-11. PubMed ID: 19650008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
    Schulz N; Püschel K; Turk EE
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator shocks increase T-wave alternans.
    Lampert R; Soufer R; McPherson CA; Batsford WP; Tirado S; Earley C; Goldberg A; Shusterman V
    J Cardiovasc Electrophysiol; 2007 May; 18(5):512-7. PubMed ID: 17428273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lost in translation: examining patient and physician perceptions of implantable cardioverter-defibrillator deactivation discussions.
    Mitar M; Alba AC; MacIver J; Ross H
    Circ Heart Fail; 2012 Sep; 5(5):660-6. PubMed ID: 22991406
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.